Brian Nolan

Brian W. Nolan helps clients achieve successful outcomes in intellectual property litigation, licensing, counseling, and due diligence across patent, trade secret, false advertising, unfair competition, antitrust, trademark, counterfeit goods, and copyright law. A member of Mayer Brown’s Artificial Intelligence Steering Committee, Brian handles matters spanning life sciences, high tech, and consumer products. Clients and rankings consistently highlight Brian’s business focus and judgment. Chambers reports that “he understands a client’s needs and applies it to the business issue at hand very effectively.” IAM 1000 notes that “Brian takes a very pragmatic approach and completely understands the business side of things.” Clients also recognize his technical acumen—from being named a “Life Sciences Star” to maintaining an “ability to cross over seamlessly into other fields such as semiconductors and information technology.”

Brian has acted as lead trial counsel and appellate counsel on numerous matters covering all aspects of intellectual property protection. He has participated in several district court trials, ITC investigations, and USPTO Post Grant proceedings and appellate matters relating to a wide range of technologies, including monoclonal antibodies, pharmaceuticals, receptor pharmacology, medical devices, biotechnology, semiconductors, OLED displays, laser diodes, computer storage systems, error detection and correction, data capture systems, medical imaging technology, crystal growth, and building products. Brian has experience counseling clients concerning their biological products, including working to develop strategies to allow for introduction of new biologics to the marketplace and seeking to protect existing biologics from potential biosimilars competition. Brian has experience litigating cases brought under the Hatch-Waxman Act and counseling innovator pharmaceutical companies regarding their patent portfolios and potential generic competition prior to patent expiry.

Brian regularly assists clients with business transactions in which IP assets and artificial intelligence form a key component. Brian advises on M&A, capital markets, and other corporate transactions, including joint ventures, collaborations, licensing, private equity, venture capital, and hedge fund transactions. Brian counsels investment companies concerning acquisitions in which the buyer's valuation is driven by IP assets. He works with public and private companies to develop patent strategies to enhance overall value.